Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Azithromycin's short course isn't a shortcut — it reflects unique pharmacokinetics that let the drug keep working long after the last pill.
Long-term, low-dose azithromycin reduces flare-ups in COPD and bronchiectasis in well-conducted trials—but the benefit carries real trade-offs worth understanding.
How bacteria evolve resistance to antibiotics, and why metals like silver behave differently — plus what chitosan is and where hygiene fits in.
Praziquantel kills schistosome blood flukes by forcing calcium into their muscle cells, causing paralysis and exposing them to immune attack—a mechanism decades in the unraveling.
Mebendazole kills intestinal parasites by disrupting microtubules. That same mechanism is why researchers are cautiously studying it in cancer.
Alcohol and metal- or polymer-based antimicrobials kill germs by entirely different routes. Understanding the mechanisms clarifies what each can and cannot reasonably be expected to do.
Ivermectin is dosed in micrograms per kilogram, not by the pill. Understanding why body weight—not tablet count—determines safety and effect.
Azithromycin lingers in tissues long after blood levels fall, thanks to cellular trapping and immune-cell transport. Here's the real pharmacology behind it.
Streptococcus pneumoniae has developed real, well-documented resistance to azithromycin and related macrolides. Here is what the evidence shows about how and why.